IP Library Granted Patent US 12,084,670
Granted Patent B2
US 12,084,670 · App. 18/093,784 · Granted Sep 10, 2024

Regulating alkaloids

Inventors: Takashi Hashimoto (Ikoma, JP); Akira Kato (Nara, JP)
Assignee: 22nd Century Limited, LLC
C12N15/8218A24B13/00A24B15/10A61K31/455C12N9/0004C12N9/0012C12N9/0022C12N15/8216C12N15/8243C12N15/8279C12N15/8286C12Y104/03006Y02A40/146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,084,670
App. No.
18/093,784
Granted
Sep 10, 2024
Kind
B2
Abstract

MPO1 and MPO2 can be regulated for either decreasing or increasing alkaloid levels in plants, in particular in Nicotiana plants. In particular, suppressing or overexpressing one or more of MPO1 and MPO2 may be used to decrease or increase nicotine and nicotinic alkaloid levels in tobacco plants. Suppression or overexpression of one or more of MPO1 and MPO2 may be used in combination with modification of expression of other genes encoding enzymes on the nicotinic alkaloid biosynthetic pathway such as A622, NBB1, PMT, and QPT.

Claims (10)

1. A method for increasing the ratio of nicotine to total alkaloids in a tobacco plant, comprising:

(a) introducing into the plant a nucleic acid construct comprising:

(i) an expression cassette comprising at least one nucleotide sequence selected from the group consisting of a nucleotide sequence set forth in SEQ ID NO: 1, a nucleotide sequence set forth in SEQ ID NO: 5, and a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2;

(ii) a putrescine N-methyltransferase (PMT) expression cassette; and

(iii) a quinolate phosphoribosyl transferase (QPT) suppression cassette; and

(b) growing the plant under conditions which allow for overexpression of MPO1, overexpression of PMT, and suppression of QPT,

wherein overexpression of MPO1, overexpression of PMT, and suppression of QPT results in the plant having an increased ratio of nicotine to total alkaloids in the plant as compared to a non-transformed control plant.

2. A plant produced by the method of claim 1 , wherein the plant comprises the nucleic acid construct.

3. A product with an increased nicotine to total alkaloids ratio produced from the plant of claim 2 , wherein the product has an increased nicotine to total alkaloids ratio as compared to a similar product produced from a control plant.

4. The product of claim 3 , wherein the product is selected from the group consisting of a cigarette, cigar, pipe tobacco, snus, snuff, and chewing tobacco.